Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Illustration: Rebecca Zisser/Axios
Livongo Health, a digital health startup focused on managing chronic conditions like diabetes and hypertension, raised $105 million in VC funding co-led by return backers General Catalyst and Kinnevik.
Why it's a big deal: Because it's big-money validation that the future of chronic disease monitoring will be done via connected mobile devices.
Cap table: Echo Health Ventures was the only new money, while other insiders included DFJ, Kleiner Perkins, Merck, Microsoft Ventures, Sapphire Ventures, 7wire Ventures and Zaffre Investments.
Bottom line: "Diabetes [is seen] as a significant driver of premium increases with more than 30 million Americans, or 9% of the U.S. population, suffering from diabetes, according to the American Diabetes Association. Another estimated 30 million Americans have diabetes but have yet to have it diagnosed, ADA statistics show." — Bruce Japsen, Forbes